vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Mastech Digital, Inc. (MHH). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $45.5M, roughly 1.8× Mastech Digital, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs 2.1%, a 4.7% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -10.4%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $4.3M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.
BLLN vs MHH — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $45.5M |
| Net Profit | $5.7M | $972.0K |
| Gross Margin | 69.9% | 28.3% |
| Operating Margin | 11.5% | 2.2% |
| Net Margin | 6.8% | 2.1% |
| Revenue YoY | 117.4% | -10.4% |
| Net Profit YoY | 138.3% | 227.3% |
| EPS (diluted) | $0.10 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $45.5M | ||
| Q3 25 | $83.5M | $48.5M | ||
| Q2 25 | — | $49.1M | ||
| Q1 25 | — | $48.3M | ||
| Q4 24 | $45.1M | $50.7M | ||
| Q3 24 | $38.4M | $51.8M | ||
| Q2 24 | — | $49.5M | ||
| Q1 24 | — | $46.8M |
| Q4 25 | — | $972.0K | ||
| Q3 25 | $5.7M | $941.0K | ||
| Q2 25 | — | $135.0K | ||
| Q1 25 | — | $-1.4M | ||
| Q4 24 | $-11.5M | $297.0K | ||
| Q3 24 | $-14.9M | $1.9M | ||
| Q2 24 | — | $1.4M | ||
| Q1 24 | — | $-161.0K |
| Q4 25 | — | 28.3% | ||
| Q3 25 | 69.9% | 27.8% | ||
| Q2 25 | — | 28.1% | ||
| Q1 25 | — | 26.7% | ||
| Q4 24 | 57.1% | 29.0% | ||
| Q3 24 | 52.6% | 28.5% | ||
| Q2 24 | — | 28.2% | ||
| Q1 24 | — | 25.9% |
| Q4 25 | — | 2.2% | ||
| Q3 25 | 11.5% | 1.7% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | -3.8% | ||
| Q4 24 | 17.0% | 0.1% | ||
| Q3 24 | -32.9% | 4.7% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | -0.9% |
| Q4 25 | — | 2.1% | ||
| Q3 25 | 6.8% | 1.9% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | -3.0% | ||
| Q4 24 | -25.5% | 0.6% | ||
| Q3 24 | -38.8% | 3.6% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | -0.3% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | $0.10 | $0.08 | ||
| Q2 25 | — | $0.01 | ||
| Q1 25 | — | $-0.12 | ||
| Q4 24 | $-1.13 | $0.01 | ||
| Q3 24 | $-1.47 | $0.16 | ||
| Q2 24 | — | $0.12 | ||
| Q1 24 | — | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $36.5M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $89.3M |
| Total Assets | $327.5M | $111.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $36.5M | ||
| Q3 25 | $195.2M | $32.7M | ||
| Q2 25 | — | $27.9M | ||
| Q1 25 | — | $24.7M | ||
| Q4 24 | $191.5M | $27.7M | ||
| Q3 24 | — | $23.9M | ||
| Q2 24 | — | $20.6M | ||
| Q1 24 | — | $19.4M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $89.3M | ||
| Q3 25 | $-239.5M | $88.0M | ||
| Q2 25 | — | $87.8M | ||
| Q1 25 | — | $86.9M | ||
| Q4 24 | $-251.7M | $87.4M | ||
| Q3 24 | $-242.9M | $86.5M | ||
| Q2 24 | — | $84.0M | ||
| Q1 24 | — | $81.7M |
| Q4 25 | — | $111.8M | ||
| Q3 25 | $327.5M | $112.6M | ||
| Q2 25 | — | $110.4M | ||
| Q1 25 | — | $110.1M | ||
| Q4 24 | $302.1M | $111.5M | ||
| Q3 24 | — | $111.5M | ||
| Q2 24 | — | $107.5M | ||
| Q1 24 | — | $106.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $4.4M |
| Free Cash FlowOCF − Capex | $6.5M | $4.3M |
| FCF MarginFCF / Revenue | 7.7% | 9.5% |
| Capex IntensityCapex / Revenue | 8.8% | 0.1% |
| Cash ConversionOCF / Net Profit | 2.42× | 4.48× |
| TTM Free Cash FlowTrailing 4 quarters | — | $10.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.4M | ||
| Q3 25 | $13.8M | $6.5M | ||
| Q2 25 | — | $3.3M | ||
| Q1 25 | — | $-3.0M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $3.3M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-1.3M |
| Q4 25 | — | $4.3M | ||
| Q3 25 | $6.5M | $6.3M | ||
| Q2 25 | — | $3.2M | ||
| Q1 25 | — | $-3.1M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $707.0K | ||
| Q1 24 | — | $-1.6M |
| Q4 25 | — | 9.5% | ||
| Q3 25 | 7.7% | 13.0% | ||
| Q2 25 | — | 6.6% | ||
| Q1 25 | — | -6.4% | ||
| Q4 24 | — | 7.7% | ||
| Q3 24 | — | 6.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | -3.4% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 8.8% | 0.4% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 4.48× | ||
| Q3 25 | 2.42× | 6.88× | ||
| Q2 25 | — | 24.41× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 13.60× | ||
| Q3 24 | — | 1.76× | ||
| Q2 24 | — | 0.85× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
MHH
| IT Staffing Services | $37.6M | 83% |
| Data And Analytics Services | $7.8M | 17% |
